858
Views
26
CrossRef citations to date
0
Altmetric
Allergy: Brief Review

Establishing the place in therapy of bilastine in the treatment of allergic rhinitis according to ARIA: evidence review

, , , , , , , , , , , , , & show all
Pages 131-139 | Accepted 05 Dec 2011, Published online: 22 Dec 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (8)

Martin K. Church, Marysia Tiongco-Recto, Erminia Ridolo & Zoltán Novák. (2020) Bilastine: a lifetime companion for the treatment of allergies. Current Medical Research and Opinion 36:3, pages 445-454.
Read now
Xue Yan Wang, Margaret Lim-Jurado, Narayanan Prepageran, Pongsakorn Tantilipikorn & De Yun Wang. (2016) Treatment of allergic rhinitis and urticaria: a review of the newest antihistamine drug bilastine. Therapeutics and Clinical Risk Management 12, pages 585-597.
Read now
Ludger Klimek, Joaquim Mullol, Peter Hellings, Philippe Gevaert, Ralph Mösges & Wytske Fokkens. (2016) Recent pharmacological developments in the treatment of perennial and persistent allergic rhinitis. Expert Opinion on Pharmacotherapy 17:5, pages 657-669.
Read now
Ignacio Jáuregui, Johannes G Ramaekers, Kazuhiko Yanai, Magí Farré, Esther Redondo, Román Valiente & Luis Labeaga. (2016) Bilastine: a new antihistamine with an optimal benefit-to-risk ratio for safety during driving. Expert Opinion on Drug Safety 15:1, pages 89-98.
Read now
David Price, Pete Smith, Peter Hellings, Nikos Papadopoulos, Wytske Fokkens, Antonella Muraro, Ruth Murray, Alison Chisholm, Pascal Demoly, Glenis Scadding, Joaquim Mullol, Phil Lieberman, Claus Bachert, Ralph Mösges, Dermot Ryan & Jean Bousquet. (2015) Current controversies and challenges in allergic rhinitis management. Expert Review of Clinical Immunology 11:11, pages 1205-1217.
Read now
Amelia Licari, Giorgio Ciprandi, Alessia Marseglia, Riccardo Castagnoli, Salvatore Barberi, Silvia Caimmi & Gian Luigi Marseglia. (2014) Current recommendations and emerging options for the treatment of allergic rhinitis. Expert Review of Clinical Immunology 10:10, pages 1337-1347.
Read now
Belen Sadaba, Jose Ramon Azanza, Almundena Gomez-Guiu & Raquel Rodil. (2013) Critical appraisal of bilastine for the treatment of allergic rhinoconjunctivitis and urticaria. Therapeutics and Clinical Risk Management 9, pages 197-205.
Read now
Vanesa González-Núñez, Antonio Valero & Joaquim Mullol. (2013) Safety evaluation of desloratadine in allergic rhinitis. Expert Opinion on Drug Safety 12:3, pages 445-453.
Read now

Articles from other publishers (18)

Aranjit Singh Randhawa, Norhayati Mohd Noor, Mohd Khairi Md Daud & Baharudin Abdullah. (2022) Efficacy and Safety of Bilastine in the Treatment of Allergic Rhinitis: A Systematic Review and Meta-analysis. Frontiers in Pharmacology 12.
Crossref
NAGUR SHARONE GRACE, SYED ARSHADDUDDIN AHMED, BHUVANESWARI E, SYED HAMZA QUADRI, VEENA B, MONICA N & VALISHETTI MANOJ KUMAR. (2021) TO EVALUATE EFFICACY AND SAFETY OF RUPATADINE, BILASTINE, AND LEVOCETRIZINE IN ALLERGIC RHINITIS AT TERITARY CARE HOSPITAL, TELANGANA. Asian Journal of Pharmaceutical and Clinical Research, pages 140-143.
Crossref
D. V. Shabanov & Ju. E. Lutkovskaya. (2020) Actual antihistamine therapy. Meditsinskiy sovet = Medical Council:16, pages 26-35.
Crossref
. (2019) Act quickly when treating atopic keratoconjunctivitis to avoid adverse outcomes. Drugs & Therapy Perspectives 36:1, pages 17-22.
Crossref
Mario Sánchez-Borges & Ignacio J. Ansotegui. (2019) Second generation antihistamines: an update. Current Opinion in Allergy & Clinical Immunology 19:4, pages 358-364.
Crossref
Erminia Ridolo, P. Kihlgren, I. Pellicelli, M. C. Nizi, F. Pucciarini & C. Incorvaia. (2019) Atopic Keratoconjunctivitis: Pharmacotherapy for the Elderly. Drugs & Aging 36:7, pages 581-588.
Crossref
D. V. Shabanov & V. N. Fedoseeva. (2019) Modern aspects of treatment of allergic rhinitis. Medical Council:8, pages 54-59.
Crossref
Jarmila Čelakovská. (2019) Urticaria - review of disease and treatment, new antihistamine bilastin. Dermatologie pro praxi 13:1, pages 21-24.
Crossref
Li‐Ping Zhao & Xing‐Hua Gao. 2019. Advances in Integrative Dermatology. Advances in Integrative Dermatology 145 162 .
M.K. Church & L. Labeaga. (2017) Bilastine: a new H 1 ‐antihistamine with an optimal profile for updosing in urticaria . Journal of the European Academy of Dermatology and Venereology 31:9, pages 1447-1452.
Crossref
Katherine A. Lyseng-Williamson. (2017) Bilastine in symptomatic allergic rhinoconjunctivitis and urticaria: a guide to its use. Drugs & Therapy Perspectives 33:3, pages 102-109.
Crossref
Piotr Kuna, Dariusz Jurkiewicz, Magdalena M. Czarnecka-Operacz, Rafał Pawliczak, Jarosław Woroń, Marcin Moniuszko & Andrzej Emeryk. (2017) The role and choice criteria of antihistamines in allergy management – Expert opinion. Alergologia Polska - Polish Journal of Allergology 4:1, pages 7-19.
Crossref
Ralph MösgesDennis Lip Yen LeeJovilia AbongBella SiasocoSteven KW ChowJern-Lin LeongHarvinder SinghS KuljitBenjamin Campomanes. (2016) Role of bilastine in the management of allergic rhinitis and urticaria: an Asia-Pacific consensus statement. Asia Pacific Allergy 6:1, pages 56.
Crossref
Erminia Ridolo, Marcello Montagni, Laura Bonzano, Cristoforo Incorvaia & Giorgio Walter Canonica. (2015) Bilastine: new insight into antihistamine treatment. Clinical and Molecular Allergy 13:1.
Crossref
Fulvio Braido, Federica Arcadipane, Fiorenza Marugo, Mituki Hayashi & Ruby Pawankar. (2014) Allergic rhinitis. Current Opinion in Allergy & Clinical Immunology 14:2, pages 168-176.
Crossref
F. Estelle R. Simons & Cezmi A. Akdis. 2014. Middleton's Allergy. Middleton's Allergy 1503 1533 .
Ole D. Wolthers. (2013) Bilastine: A New Nonsedating Oral H1 Antihistamine for Treatment of Allergic Rhinoconjunctivitis and Urticaria. BioMed Research International 2013, pages 1-6.
Crossref
Katherine A. Lyseng-Williamson & Natalie A. Carter. (2012) Bilastine: a guide to its use in the treatment of symptomatic allergic rhinoconjunctivitis and urticaria. Drugs & Therapy Perspectives 28:11, pages 1-5.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.